Freelite測(cè)定法由兩種敏感而特異性的**診斷測(cè)試組成,可測(cè)量kappa(κ)和lambda(λ)游離輕鏈
這是國(guó)家和國(guó)際準(zhǔn)則推薦的唯壹免費(fèi)的輕鏈檢測(cè)方法
Freelite是一種簡(jiǎn)單的多克隆抗體血清測(cè)試,用于檢測(cè)包括多發(fā)性骨髓瘤在內(nèi)的單克隆血友病。 該測(cè)試提供了快速而高度敏感的結(jié)果,這些結(jié)果在以下方面起著重要作用:
Freelite定量測(cè)量血清Kappa和Lambda自由輕鏈(FLC),可用于懷疑患有單克隆血友病的患者的初步檢測(cè),監(jiān)測(cè)和預(yù)后。
進(jìn)行Freelite和血清電泳分析可提供有效的初始診斷屏幕,這意味著可以更選擇性地訂購尿液電泳。
The Freelite assay is composed of two sensitive and specific immunodiagnostic tests to measure kappa (κ) and lambda (λ) free light chains
It is the only free light chain assay recommended by national and international guidelines
Freelite is a simple, polyclonal antibody serum test for monoclonal gammopathies including Multiple Myeloma The test provides rapid and highly sensitive results that play an important role in:
Freelite quantitatively measures serum kappa and lambda free light chains (FLCs) and can be used in initial testing, monitoring and prognosis of patients with suspected monoclonal gammopathies.
Performing Freelite and serum electrophoresis analysis provides an efficient initial diagnostic screen, and means that urine electrophoresis can be ordered more selectively.